Google Chrome
Safari
Firefox
Edge
Press Release / Jun 18, 2024
Hovione Unveils New Continuous Tableting Line at Lisbon R&D Centre
Hovione is proud to announce the opening of a state-of-the-art continuous tableting (CT) line at its R&D Center in Lisbon.
Search
Article / Mar 26, 2026
As expansions come online, CDMO Hovione aims to meet industry's 'dual supply and sourcing' zeal: exec
Fierce Pharma, 26 March 2026
News / May 06, 2021
Science Turnaround - Case Studies
Case Studies presented by our scientists: how alternative scenarios accelerated progress and improved results allowing our clients’ products to perform better.
Press Release / May 27, 2021
Hovione and iBET announce strategic collaboration
A strategic partnership that will take Hovione to new technology frontiers.
Press Release / Nov 22, 2021
Hovione announces New Pharma Campus expansion in New Jersey
This expansion in New Jersey will create up to 100 jobs over the next few years is part of a global expansion strategy
Article / Oct 10, 2022
Hovione’s Continuous Manufacturing Facility, Loures, Portugal
Pharmaceutical Technology, 10 October 2022
Press Release / Nov 29, 2023
Hovione expands nasal drug delivery capabilities with the development of nasal powder delivery device technology in collaboration with IDC
Hovione, the specialist integrated CDMO, just announced an expansion of its nasal drug delivery capabilities with the addition of a family of innovative nasal powder delivery devices developed in partnership with IDC.
Article / Sep 24, 2024
Formulating Inhaled Medicines
Excipient and delivery device selection play crucial roles in the formulation of inhaled drugs.
News / Jul 20, 2021
ASD-HIPROS Learning Lab at CPhI NA
Join our exclusive Learning Lab at CPhI North America